ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.
about
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaZAP-70 in B cell malignanciesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaCellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease courseB cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsNew molecular markers in resistant B-CLL.Update on risk-stratified management for chronic lymphocytic leukemia.The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.Differential and tumor-specific expression of CD160 in B-cell malignancies.Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.Detection methods of ZAP-70 in chronic lymphocytic leukemia.Shaping the niche: lessons from the Drosophila testis and other model systems.Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia.B cell receptor signaling in chronic lymphocytic leukemia.ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
P2860
Q28248800-E809C67E-9BDD-4183-8F60-52D08E41D28BQ28279902-C829F0D4-F0BC-4273-B229-96538367EAE8Q28282822-8625DD88-B199-4BA0-9FFF-9C618F7B7517Q33350258-2C533D53-87F0-45E1-8FA0-F726B51FC5FFQ33822016-3EE64E54-8AC8-47E4-AF34-929BEB832987Q35954301-E23B0D3A-750D-4F10-8696-9C39098AF7E0Q36251887-B9B61A40-C6E8-4C18-A159-156829355D6CQ36291109-6623E4E5-1689-49DC-B348-2A471330C934Q36384860-55DA3B76-B36C-4D67-BF0D-995F98AA5598Q36462397-199B8DAB-AD08-42FA-9ECA-069DEB713FB7Q36497411-92052774-F464-4712-89DD-57E7493A23D6Q36634599-8ED37972-0BC6-4880-AE0B-3E71426C7FF6Q36849336-99410897-39FC-4371-A5F4-F35A6C92D0EFQ37625491-72D6F273-C8E8-46A6-A682-EA4DF0CCA382Q37771664-DE90E697-2053-4F67-8D1E-CC7B8BB09A6EQ37892409-FAEB15CE-E714-4DC4-B62A-E30F164BB0B2Q38001403-3309A5C4-9604-4F05-AF9E-D23C31716B54Q38042778-DC67CF1B-0FB8-447B-B942-C1C8C9841105Q38127513-FB875FD5-6749-4E89-8498-CDD7E20C4F65Q40003594-3298FCEA-C27E-4363-967F-495FB98503C3Q40315561-E5189E76-18CF-493B-BA47-4BF4C75750B4Q52579132-E8F2F69C-D5C5-438C-96CC-D5323265DBDE
P2860
ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@en
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@nl
type
label
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@en
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@nl
prefLabel
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@en
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@nl
P2093
P2860
P356
P1433
P1476
ZAP-70 is expressed by a subse ...... laying an activated phenotype.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403726
P577
2005-06-01T00:00:00Z